Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferizyme
- Development stage
- Unknown
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
"Ferizyme" is a brand name used for multiple digestive enzyme products in South Asia. One formulation, Ferizyme Tablets (manufactured by Greek Tec), is a pancreatic enzyme supplement containing pancreatin as its active ingredient, which is used to treat pancreatic enzyme deficiency and aid in the digestion of fats, starches, and proteins. Another formulation, Ferizyme Paed Drops or Syrup (manufactured by Ikon Remedies), is a fixed-dose combination of the digestive enzymes diastase (alpha-amylase) and pepsin, used in infants and children to treat indigestion and associated symptoms such as gas and bloating. These enzyme preparations act directly on dietary substrates to facilitate digestion.
- Brand names
- FerizymeFerizyme Paed DropsFerizyme SyrupFerizyme Tablets
Beyond the preview
Go deeper on Ferizyme.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ferizyme.